openPR Logo
Press release

Biochip Market Growth by $21.42 Bn, Globally at Expected CAGR In Upcoming Year Report Forecast to 2020 To 2027

02-28-2020 04:32 PM CET | Health & Medicine

Press release from: Allied Market Research

Biochip Market

Biochip Market

"Biochip Market by Product (DNA Chips, Protein Chips, Lab-On-A-Chip, and Others), Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture, and Other), and End User (Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers, Academic & Research Institutes, and Other): Global Opportunity Analysis and Industry Forecast, 2019-2027".

The report presents a detailed analysis of the driving factors & opportunities, top-winning strategies, business performance of key players, top investment pockets, and competitive landscape. According to the report, the global biochip market was pegged at $9.04 billion in 2017 and is expected to reach $21.42 billion by 2025, registering a CAGR of 11.2% from 2018 to 2025.

Download Sample PDF Of Report@ https://www.alliedmarketresearch.com/request-sample/4359

Technological advancements in the sector and increased utilization in personalized medicines, cancer diagnostics, and treatment drive the growth of the global biochip market. However, high cost of R&D activities related to biochips hampers the market growth. On the other hand, improving the feasibility of biochips in drug discovery, proteomics, and genomics offers lucrative opportunities to the market players in future.

DNA chips segment to dominate the market: -

In 2017, the DNA chips segment dominated the market in terms of revenue, contributing more than one-third share, as they are cost effective and have widespread availability. However, the protein chips segment is expected to manifest the fastest CAGR of 12.9% by 2025, owing to the recent technological advancements. In addition, the lab-on-a-chip segment is expected to portray gradual growth during the forecast period.

Major market players: -

The key companies analyzed in the report include Abbott Laboratories, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific, Inc., Agilent Technologies Inc., Fluidigm Corporation, GE Healthcare, Cepheid Inc., and F. Hoffmann-La Roche AG. In addition, the report highlights key market strategies, such as partnerships, collaboration, mergers & acquisition, and new product launch, which have been adopted by these market players to sustain the intense competition in the industry.

Major application areas of the industry: -

The report analyzed key application areas including drug discovery & development, disease diagnostics, genomics, proteomics, agriculture, and others. In 2017, drug discovery & development segment accounted about 30% share of the total market, as biochips are widely used to identify the active ingredients of drugs. However, disease diagnostics segment is estimated to grow at the fastest CAGR of 12.2% through 2025, owing to the surge in use of biochips for detection of cancer and other immunological disorders.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/4359

Biotechnology & pharmaceutical Companies segment to dominate the industry by 2025:-

Biotechnology & pharmaceutical companies segment contributed about two-thirds share of the total market, owing to high investment required for the development of a variety of biochip products. However, academic & research institutes segment is expected to register the fastest CAGR of 13.5% from 2018 to 2025, owing to the development of portable and user-friendly biochips, which can be used for academic purposes. In addition, the hospitals and diagnostics centers segment would show gradual growth during the study period.

Asia-Pacific region to portray fastest growth by 2025 :-

In 2017, Asia-Pacific region garnered about $2.02 billion and is expected to register the fastest CAGR of 12.4% during the forecast period owing to various factors such as rapidly changing healthcare infrastructure in developing economies including India and China. However, in 2017, North America was the largest revenue contributor to the global biochip market, accounting for about 41% share, owing to rise in adoption of advanced biochips and high competitor interest in the under-penetrated market.

Read More About This Report@ https://www.alliedmarketresearch.com/biochip-market

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biochip Market Growth by $21.42 Bn, Globally at Expected CAGR In Upcoming Year Report Forecast to 2020 To 2027 here

News-ID: 1949908 • Views: 266

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Biochip

Biochip Market Trends & Outlook 2019 | Danaher Corp., Illumina, Inc., Qiagen N.V …
The biochips market growth outlook is positive with significant growth potential for DNA microarray. There is pressure on biochip manufacturers to reduce prices of biochips from medical diagnostic companies and research organizations as biochip prices are limiting the growth of the market. At the same time, increasing use of biochips in pharmaceutical research and development activities, concerns regarding animal testing, rising use of DNA microarrays for cancer diagnosis is contributing
Biochip Market To Achieve Significant Gains and Forecast Between 2018 to 2025
Qyresearchreports include new market research report “Global Biochip Market Professional Survey Report 2018” to its huge collection of research reports. In molecular biology, biochips are essentially miniaturized laboratories that can perform hundreds or thousands of simultaneous biochemical reactions. Biochips enable researchers to quickly screen large numbers of biological analytes for a variety of purposes, from disease diagnosis to detection of bioterrorism agents. Digital microfluidic biochips have become one of the most
Biochip Products Market Research Analysis By Experts 2018 To 2025
Qyresearchreports include new market research report “Global Biochip Products Sales Market Report 2018” to its huge collection of research reports. Global Biochip Products market competition by top manufacturers/players, with Biochip Products sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including Illumina Thermo Fisher Scientific Cellix GE Healthcare Randox BioDot PerkinElmer Roche Horiba Download Free exclusive Sample of this report: https://www.qyresearchreports.com/sample/sample.php?rep_id=1507482&type=S As every market is characterized by a unique set of competition between key players,
Global Biochip Market Professional Survey Report 2017
Researchmoz added Most up-to-date research on "Global Biochip Market Professional Survey Report 2017" to its huge collection of research reports. This report studies Biochip in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share
Biochip Market 2017 Trend, Analysis and Forecast to 2021
Biochips are bio-microsystems. Bio-microsystems are small integrated devices used for biochemical reactions, biological monitoring, research, academic studies, drug discovery, and much more. In simple terms, biochips are small sized chips that can perform multiple (generally thousands) biochemical reactions parallelly. A collection of microarrays or micro-test sites form these biochips. Microarrays when arranged on a surface made up of either glass or silicon, can perform large numbers of tests at the
Biochip Market Analysis by Application and Trend 2017-2021
Biochips allow simultaneous testing of higher number of analytes to achieve high throughput and low cost per test. Nanotechnology has helped in miniaturization of devices to achieve higher performance standards. Microarrays are most important part of biochips which send signals to the biochip to deliver end results. Microfluidic biochips have become modern alternative to routine laboratories. Microfluidic technology which enables controlling flow of liquids in micro and pico quantities has